SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Neurology Today in 5
English - March 21, 2024 03:00 - 4 minutes - 6.35 MB - ★★★★★ - 14 ratingsScience Health & Fitness Medicine neurology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.